Background Image
Previous Page  25 / 32 Next Page
Information
Show Menu
Previous Page 25 / 32 Next Page
Page Background

MALAYSIA

FOCUS

| December 2014

25

EBOLA VIRUS

are available yet, but 2 potential vaccines are

undergoing human safety testing.

Prevention and control

Good outbreak control relies on applying a package

of interventions, namely case management,

surveillance and contact tracing, a good laboratory

service, safe burials and social mobilisation.

Community engagement is a key to successfully

controlling outbreaks. Raising awareness of risk

factors for Ebola infection and protective measures

that individuals can take is an effectiveway to reduce

human transmission. Risk reduction messaging

should focus on several factors:

•

Reducing the risk of wildlife-to-human

transmission

from contact with infected fruit

bats or monkeys/apes and the consumption of

their raw meat. Animals should be handled with

gloves and other appropriate protective clothing.

Animal products (blood and meat) should be

thoroughly cooked before consumption.

•

Reducing the risk of human-to-human

transmission

from direct or close contact with

people with Ebola symptoms, particularly with

their bodily fluids. Gloves and appropriate

personal protective equipment should be worn

when taking care of ill patients at home. Regular

hand washing is required after visiting patients in

hospital, as well as after taking care of patients at

home.

•

Outbreak containment measures

including

prompt and safe burial of the dead, identifying

people who may have been in contact with

someone infected with Ebola, monitoring the

health of contacts for 21 days, the importance of

separating the healthy from the sick to prevent

further spread, the importance of good hygiene

and maintaining a clean environment.

Diagnosis

It can be difficult to distinguish Ebola from other

infectious diseases such as malaria, typhoid fever

and meningitis. Confirmation that symptoms are

caused by Ebola virus infection are made using the

following investigations:

• antibody-capture enzyme-linked

immunosorbent assay (ELISA)

• antigen-capture detection tests

• serum neutralization test

• reverse transcriptase polymerase chain reaction

(RT-PCR) assay

• electron microscopy

• Virus isolation by cell culture.

Samples from patients are an extreme biohazard

risk; laboratory testing on non-inactivated samples

should be conducted under maximum biological

containment conditions.

Treatment and vaccines

Supportive

care-rehydration

with

oral

or

intravenous fluids- and treatment of specific

symptoms, improves survival. There is as yet no

proven treatment available for Ebola. However,

a range of potential treatments including blood

products, immune therapies and drug therapies

are currently being evaluated. No licensed vaccines